Medical Facilities Corporation

TSX:DR.TO

Medical - Care Facilities

Healthcare
$17.43 +1.01%

+$0.18 today

Market cap
$282.59M
Beta
0.34
P/E (TTM)
8.7
EPS (TTM)
$1.47
Dividend yield
2.00%
52W Low $13.59High $18.79

Volume 0.04M

Average 0.02M

DR.TO Weighted Avg Shares

Average number of basic shares outstanding during the period, used to calculate basic EPS.

Medical Facilities CorporationTSX: DR.TO

Weighted Avg Shares · Q1 FY2026 · quarter ended Mar 2026

Weighted avg shares declines year over year

Q1 FY2026 weighted avg shares of 17.7M shares fell 20.2% year over year, behind the -3.7% change in trailing-twelve-month weighted avg shares. Sequentially, it fell 0.9% from the prior quarter. Over 3 fiscal years it compounded at -12.8% a year.

Context

  • Weighted avg shares increased in 1 of the last 3 fiscal years.

What to watch

Whether quarterly growth recovers from -20.2% toward the trailing-twelve-month pace of -3.7%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
17.7M-0.9% QoQ
Last fiscal yearDec 2025
19.48M+5.3% YoY
LTMMar 2026
18.7M-3.7% YoY
Weighted Avg Shares past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-20.2%——
1 year+5.3%——
3-year CAGR-12.8%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares history

Shares · from the income statement

Latest · FY2025
19.48M USD
Year-over-year change
+5.3%
4-year CAGR
-11.0%

Weighted Avg Shares vs competitors

How DR.TO compares with its peers on the latest reported figures

  • DR.TO's LTM Mar 2026 weighted avg shares of 18.7M shares is the lowest of the 9 companies compared; the peer median is 98.29M shares.
  • Its year-over-year change of -3.7% is the lowest of 9, against a peer median of +14.4%.
  • Over three fiscal years its annual growth of -12.8% compares with a peer median of +9.6%.
DR.TO Competitors Peer median
Weighted Avg Shares for DR.TO and competitors
Company Period LTM YoY 3-year CAGR
XLY.TOAuxly Cannabis Group Inc.LTM Mar 20261.35B +5.3%+14.3%
TSND.TOTerrAscend Corp.LTM Mar 2026305.61M +9.1%+7.2%
WEED.TOCanopy Growth CorporationLTM Mar 2026288.35M +167.7%+8.4%
OGI.TOOrganiGram Holdings Inc.LTM Mar 2026133.64M +18.4%—
CRRX.TOCareRx CorporationLTM Mar 202662.94M +2.7%+9.6%
EPRX.TOEupraxia Pharmaceuticals Inc.LTM Mar 202644.51M +24.9%+27.5%
PRN.TOProfound Medical Corp.LTM Mar 202631.8M +21.4%+13.3%
FRX.TOFennec Pharmaceuticals Inc.LTM Mar 202630.27M +10.4%+2.8%
DR.TOMedical Facilities CorporationLTM Mar 202618.7M -3.7%-12.8%
Peer median (excluding DR.TO) 98.29M+14.4%+9.6%

Competitors are the stored peer set for DR.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue398.63M424.55M445.58M331.53M258.62M
Cost of Revenue130.03M143.93M148.9M111.65M160.42M
Gross Profit268.61M280.63M296.68M219.88M98.2M
Gross Margin67.4%66.1%66.6%66.3%38.0%
Research & Development00000
Selling, General & Admin177.58M198.21M151.73M151.12M119.23M
Operating Expenses191.25M245.69M229.57M158.24M50.72M
Depreciation & Amortization26.77M20.76M21.54M19.37M11.94M
EBITDA103.4M51.15M72.43M82.57M59.41M
EBITDA Margin25.9%12.0%16.3%24.9%23.0%
Operating Income77.36M34.94M67.11M61.64M47.47M
Operating Margin19.4%8.2%15.1%18.6%18.4%
Interest Income76K8.54M717K1.87M2.24M
Interest Expense25.74M12.89M16.5M12.09M3.59M
Other Income / Expenses(26.47M)(17.44M)(14.27M)(10.53M)(7.19M)
Income Before Tax50.89M17.5M52.32M51.11M40.28M
Pre-Tax Margin12.8%4.1%11.7%15.4%15.6%
Income Tax Expense4.4M5.21M8.33M(5.69M)5.06M
Net Income15.5M(4.41M)18.5M73.49M21.08M
Net Margin3.9%-1.0%4.2%22.2%8.2%
EPS (Basic)1.500.420.731.031.09
EPS (Diluted)1.490.420.731.031.09
Weighted Avg Shares31.09M29.37M25.35M18.5M19.48M
Weighted Avg Shares (Diluted)31.13M29.37M25.25M24M19.48M

Medical Facilities Corporation

TSX:DR.TO

Intrinsic Alpha fair value

Locked

Current Price

$17.43

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.